JACC-Cardiovascular interventions, 13(3), 323-331. Elsevier Inc. Van Mieghem, N M, Popma, J J, Deeb, G M, Yakubov, S J, Serruys, P W, Windecker, S, Søndergaard, L, Mumtaz, M, Gada, H, Chetcuti, S, Kleiman, N S, Kodali, S, George, I, Teefy, P, Kiaii, B, Oh, J K, Kappetein, A P, Chang, Y, Mugglin, A S, Reardon, M J, Sorajja, P, Sun, B, Agarwal, H, Langdon, T, den Heijer, P, Bentala, M, O'Hair, D, Bajwa, T, Byrne, T, Caskey, M, Paulus, B, Garrett, E, Stoler, R, Hebeler, R, Khabbaz, K, Lim, D S, Bladergroen, M, Fail, P, Feinberg, E, Rinaldi, M, Skipper, E, Chawla, A, Hockmuth, D, Makkar, R, Cheng, W, Aji, J, Bowen, F, Schreiber, T, Henry, S, Hengstenberg, C & SURTAVI Trial Investigators 2020, ' Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial ', JACC: Cardiovascular Interventions, vol. 13, no. 3, pp. 323-331 . https://doi.org/10.1016/j.jcin.2019.10.043
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease, 10(7). WILEY Journal of the American Heart Association, 10(7):e019236. Wiley-Blackwell Publishing Ltd